Disease Management Clinical Decisions
The Immunologic Basis of Wellness: How personal behavior influences rheumatoid arthritis
Release date: June 24, 2019
Expiration date: June 24, 2022
Estimated Time of Completion: 45 minutes
Description
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:
Cassandra Calabrese, DO | ||
GlaxoSmithKline | Advisory Board | |
Sanofi/Regeneron | Teaching and Speaking | |
Leonard Calabrese, DO | ||
Abbvie Pharmaceuticals | Consulting Teaching and Speaking |
|
BMS | Consulting Teaching and Speaking |
|
Crescendo | Teaching and Speaking | |
GSK | Consulting | |
Genentech/Roche | Consulting Teaching and Speaking |
|
Horizon Pharma | Consulting | |
Janssen | Consulting Teaching and Speaking |
|
Novartis | Consulting Teaching and Speaking |
|
Pfizer | Consulting | |
Regeneron | Consulting | |
Sanofi Aventis | Consulting | |
UCB | Consulting | |
Anthony Fernandez, MD, PhD | ||
Novartis | Consulting;
Independent contractor (including contracted research);
Teaching and Speaking |
|
Abbvie Pharmaceuticals | Consulting; Teaching and Speaking | |
Celgene Corporation | Consulting | |
Mallinckrodt Inc. | Independent contractor (including contracted research); Teaching and Speaking |
|
Pfizer, Inc. | Independent contractor (including contracted research) | |
Roche Pharmaceuticals | Principal Investigator for a Phase III Clinical Trial |
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education.
RJ Fasenmyer Center for Clinical Immunology has a web-based, e-coached wellness program for practitioners caring for patients with an IMID. The program is evidence-based, designed to complement therapies for IMIDs, and will uniquely convey a message to patients that their personal behaviors can affect the driver of their illness: their immune system. This is a message of empowerment, a technique known to enhance behavioral change.
Learn more at www.ClevelandClinicWellness.com/Immune